118 related articles for article (PubMed ID: 10644281)
1. Rosiglitazone and hepatic failure.
Freid J; Everitt D; Boscia J
Ann Intern Med; 2000 Jan; 132(2):164. PubMed ID: 10644281
[No Abstract] [Full Text] [Related]
2. Hepatic failure in a patient taking rosiglitazone.
Forman LM; Simmons DA; Diamond RH
Ann Intern Med; 2000 Jan; 132(2):118-21. PubMed ID: 10644272
[TBL] [Abstract][Full Text] [Related]
3. Liver failure in a patient treated with long-term rosiglitazone therapy.
Gouda HE; Khan A; Schwartz J; Cohen RI
Am J Med; 2001 Nov; 111(7):584-5. PubMed ID: 11705443
[No Abstract] [Full Text] [Related]
4. Rosiglitazone (Avandia): hepatic, cardiac and hematological reactions.
McMorran M; Vu D
CMAJ; 2001 Jul; 165(1):82-3, 86-7. PubMed ID: 11468963
[No Abstract] [Full Text] [Related]
5. Failure to develop hepatic injury from rosiglitazone in a patient with a history of troglitazone-induced hepatitis.
Lenhard MJ; Funk WB
Diabetes Care; 2001 Jan; 24(1):168-9. PubMed ID: 11194222
[No Abstract] [Full Text] [Related]
6. Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction.
Lebovitz HE; Kreider M; Freed MI
Diabetes Care; 2002 May; 25(5):815-21. PubMed ID: 11978674
[TBL] [Abstract][Full Text] [Related]
7. Correction: Liver injury and rosiglitazone.
Ann Intern Med; 2000 Aug; 133(3):237. PubMed ID: 10906846
[No Abstract] [Full Text] [Related]
8. Rosiglitazone toxicity.
Ravinuthala RS; Nori U
Ann Intern Med; 2000 Oct; 133(8):658. PubMed ID: 11033603
[No Abstract] [Full Text] [Related]
9. Troglitazone-associated hepatic failure.
Booth AM; Caldwell SH; Iezzoni JC
Am J Gastroenterol; 2000 Feb; 95(2):557-8. PubMed ID: 10685776
[No Abstract] [Full Text] [Related]
10. Rosiglitazone.
Diabetes Obes Metab; 2000 Apr; 2(2):117. PubMed ID: 11220523
[No Abstract] [Full Text] [Related]
11. Isolated elevation of alkaline phosphatase level associated with rosiglitazone.
Hachey DM; O'Neil MP; Force RW
Ann Intern Med; 2000 Nov; 133(9):752. PubMed ID: 11074926
[No Abstract] [Full Text] [Related]
12. Rosiglitazone-induced granulomatous hepatitis.
Dhawan M; Agrawal R; Ravi J; Gulati S; Silverman J; Nathan G; Raab S; Brodmerkel G
J Clin Gastroenterol; 2002; 34(5):582-4. PubMed ID: 11960075
[TBL] [Abstract][Full Text] [Related]
13. Pioglitazone-associated fulminant hepatic failure.
Chase MP; Yarze JC
Am J Gastroenterol; 2002 Feb; 97(2):502-3. PubMed ID: 11866308
[No Abstract] [Full Text] [Related]
14. Rosiglitazone (Avandia) and pioglitazone (Actos) and heart failure.
Wooltorton E
CMAJ; 2002 Jan; 166(2):219. PubMed ID: 11826947
[No Abstract] [Full Text] [Related]
15. Troglitazone-induced hepatic failure leading to liver transplantation. A case report.
Neuschwander-Tetri BA; Isley WL; Oki JC; Ramrakhiani S; Quiason SG; Phillips NJ; Brunt EM
Ann Intern Med; 1998 Jul; 129(1):38-41. PubMed ID: 9652998
[TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone and liver failure.
Isley WL; Oki JC
Ann Intern Med; 2000 Sep; 133(5):393-4. PubMed ID: 10979889
[No Abstract] [Full Text] [Related]
17. Diabetes drug Rezulin: take it, but take precautions.
Health News; 1999 May; 5(6):7. PubMed ID: 10546576
[No Abstract] [Full Text] [Related]
18. Upadate on oral treatments for type II diabetes.
Dykeman J
CANNT J; 2002; 12(1):41-2. PubMed ID: 11979652
[No Abstract] [Full Text] [Related]
19. Glitazones, glycemia, and global health status.
Isley WL
Diabetes Care; 2001 Dec; 24(12):2158-9. PubMed ID: 11723105
[No Abstract] [Full Text] [Related]
20. Nonhypoglycemic effects of thiazolidinediones.
Quesada-Gómez JM; Serrano-Alferez I
Ann Intern Med; 2001 Dec; 135(11):1007-8. PubMed ID: 11730409
[No Abstract] [Full Text] [Related]
[Next] [New Search]
